The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
Official Title: Randomized, Phase III Trial Comparing Etoposide/Cisplatin (EP) With Irinotecan/Cisplatin (IP) in Patients With Previously Untreated, Extensive Disease (ED) Small Cell Lung Cancer (SCLC)
Study ID: NCT00349492
Brief Summary: This study is a randomized, multi-center clinical trial. Patients are stratified according to performance status (ECOG 0, 1 vs 2) and institution. Patients are randomized to 1 of 2 treatment arms. Arm A: Patients receive etoposide IV on days 1, 2, 3 and cisplatin IV on day 1. Courses repeat every 3 weeks Arm B: Patients receive irinotecan IV on days 1, 8 and cisplatin IV on day 1. Coursed repeated every 3 weeks Treatment in both arms continues for 6 courses in the absence of disease progression or unacceptable toxicity. Patients are followed every 3 months for 1.5 years
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Soonchunhyang University Bucheon Hospital, Bucheon-si, , Korea, Republic of
Yeungnam University Hospital, Daegu, , Korea, Republic of
Daegu Catholic University Hospital, Daegu, , Korea, Republic of
Gyeongsang National University Hospital, Jinju, , Korea, Republic of
Seoul National University Bundang Hospital, Seongnam-Si, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Kangbuk Samsung Hospital, Seoul, , Korea, Republic of
Yonsei Cancer Center, Seoul, , Korea, Republic of
Seoul Veterans Hospital, Seoul, , Korea, Republic of
Kangnam St.Mary's Hospital, Seoul, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Chung-Ang University Medical Center, Seoul, , Korea, Republic of
Seoul Municipal Boramae Hospital, Seoul, , Korea, Republic of
St.Vincent Hospital, Suwon, , Korea, Republic of
Name: Dae Seog Heo, MD, PhD
Affiliation: Seoul National University Hospital
Role: PRINCIPAL_INVESTIGATOR